579 related articles for article (PubMed ID: 20625202)
41. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
42. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
43. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359
[TBL] [Abstract][Full Text] [Related]
44. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
45. Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix.
Lin YW; Lai HC; Lin CY; Chiou JY; Shui HA; Chang CC; Yu MH; Chu TY
Int J Gynecol Cancer; 2006; 16(3):1216-24. PubMed ID: 16803509
[TBL] [Abstract][Full Text] [Related]
46. Discrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry.
Schwacke J; Millar TP; Hammond CE; Saha A; Hoffman BJ; Romagnuolo J; Hill EG; Smolka AJ
Dig Dis Sci; 2015 Jun; 60(6):1645-54. PubMed ID: 25577268
[TBL] [Abstract][Full Text] [Related]
47. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Liu JY; Jin L; Zhao MY; Zhang X; Liu CB; Zhang YX; Li FJ; Zhou JM; Wang HJ; Li JC
Clin Chem Lab Med; 2011 Oct; 49(10):1727-33. PubMed ID: 21671803
[TBL] [Abstract][Full Text] [Related]
48. [Preliminarily screening of serum characteristic markers in acute myeloid leukemia and clinical significance].
He AL; Bai J; Huang C; Zhang WG; Yang J; Wang JL; Meng X; Tian W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1132-7. PubMed ID: 21129246
[TBL] [Abstract][Full Text] [Related]
49. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
Soltys SG; Le QT; Shi G; Tibshirani R; Giaccia AJ; Koong AC
Clin Cancer Res; 2004 Jul; 10(14):4806-12. PubMed ID: 15269156
[TBL] [Abstract][Full Text] [Related]
50. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic model of saliva peptide finger print analysis of oral squamous cell carcinoma patients using weak cation exchange magnetic beads.
Jiang WP; Wang Z; Xu LX; Peng X; Chen F
Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182373
[TBL] [Abstract][Full Text] [Related]
52. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology.
Cheng AJ; Chen LC; Chien KY; Chen YJ; Chang JT; Wang HM; Liao CT; Chen IH
Clin Chem; 2005 Dec; 51(12):2236-44. PubMed ID: 16239339
[TBL] [Abstract][Full Text] [Related]
53. [Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].
An J; Tang C; Wang N; Liu Y; Guo W; Li X; Wang Z; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):233-9. PubMed ID: 23676979
[TBL] [Abstract][Full Text] [Related]
54. Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma.
Tian WD; Li JZ; Hu SW; Peng XW; Li G; Liu X; Chen HH; Xu X; Li XP
Int J Clin Exp Pathol; 2015; 8(8):9021-31. PubMed ID: 26464644
[TBL] [Abstract][Full Text] [Related]
55. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
[TBL] [Abstract][Full Text] [Related]
56. Discrimination analysis of mass spectrometry proteomics for cervical cancer detection.
Liu C; Pan C; Shen J; Wang H; Yong L; Zhang R
Med Oncol; 2011 Dec; 28 Suppl 1():S553-9. PubMed ID: 21080108
[TBL] [Abstract][Full Text] [Related]
57. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic protein discovery using proteolytic peptide targeting and identification.
Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
[TBL] [Abstract][Full Text] [Related]
59. The differential diagnostic model for serous peptidomics in HBV carriers established by MALDI-TOF-MS analysis.
Tian L; Wang Y; Xu D; Gao Y; Wen X; Tian Y
Clin Biochem; 2014 Jan; 47(1-2):56-62. PubMed ID: 24183880
[TBL] [Abstract][Full Text] [Related]
60. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
